Alterity Therapeutics Ltd ATHE:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/18/24 EDT
2.10quote price arrow down-0.04 (-1.87%)
Volume
1,511
Close
2.14UNCH (UNCH)
Volume
24,951
52 week range
1.55 - 5.41
Loading...
  • Open1.97
  • Day High2.16
  • Day Low1.97
  • Prev Close2.01
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24

Key Stats

  • Market Cap18.682M
  • Shares Out8.73M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change-14.06

KEY STATS

  • Open1.97
  • Day High2.16
  • Day Low1.97
  • Prev Close2.01
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24
  • Market Cap18.682M
  • Shares Out8.73M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change-14.06

RATIOS/PROFITABILITY

  • EPS (TTM)-2.03
  • P/E (TTM)-1.06
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-9.104M
  • ROE (TTM)-53.72%
  • Revenue (TTM)79,429.999
  • Gross Margin (TTM)-
  • Net Margin (TTM)-9,947.97%
  • Debt To Equity (MRQ)1.45%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alterity Therapeutics Ltd

 

Profile

MORE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders...
Geoffrey Kempler
Non-Executive Chairman of the Board
David Stamler M.D.
Chief Executive Officer
Phillip Hains
Chief Financial Officer, Company Secretary
Address
L 3 460 Bourke St
Melbourne, VIC
3000
Australia

Top Peers

SYMBOLLASTCHG%CHG
MNPR
Monopar Therapeutics Inc
0.678UNCHUNCH
GNPX
Genprex Inc
2.21UNCHUNCH
IKT
Inhibikase Therapeutics Inc
2.09UNCHUNCH
NNVC
NanoViricides Inc
1.17UNCHUNCH
COCP
Cocrystal Pharma Inc
1.47UNCHUNCH